Rituximab-Mediated Sensitization of B-Non-Hodgkin's Lymphoma (NHL) to Cytotoxicity Induced by Paclitaxel, Gemcitabine, and Vinorelbine-Reference-Cited by-同舟云学术

Rituximab-Mediated Sensitization of B-Non-Hodgkin's Lymphoma (NHL) to Cytotoxicity Induced by Paclitaxel, Gemcitabine, and Vinorelbine

Published:2002-12 Issue:6 Volume:17 Page:621-630
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Emmanouilides Christos¹,Jazirehi Ali R.²,Bonavida Benjamin³

Affiliation:

1. Division of Oncology, Jonsson Comprehensive Cancer Center, UCLA School of Medicine, University of California, Los Angeles, CA 90095-1747, U.S.A.

2. Department of Microbiology, Immunology, Jonsson Comprehensive Cancer Center, UCLA School of Medicine, University of California, Los Angeles, CA 90095-1747, U.S.A.

3. Department of Microbiology, Immunology and Molecular Genetics, Jonsson Comprehensive Cancer Center, UCLA School of Medicine, University of California, Los Angeles, CA 90095-1747, U.S.A.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/108497802320970226

Reference45 articles.

1. Treatment of non-Hodgkin lymphoma

2. Paclitaxel (Taxol)

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Camptothecin enhances 131I-rituximab-induced G1-arrest and apoptosis in Burkitt lymphoma cells;Journal of Cancer Research and Therapeutics;2021

Apoptosis-promoting effect of rituximab-conjugated magnetic nanoprobes on malignant lymphoma cells with CD20 overexpression

;International Journal of Nanomedicine;2019-02

3. Drug-Free Macromolecular Therapeutics Induce Apoptosis via Calcium Influx and Mitochondrial Signaling Pathway;Macromolecular Bioscience;2017-08-14

4. CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies;Current Cancer Drug Targets;2017-05-17

5. Mechanisms of action of therapeutic antibodies for cancer;Molecular Immunology;2015-10